Gene · 92
Papers1,751
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,751
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Follistatin is a crucial chemoattractant for mouse decidualized endometrial stromal cell migration by JNK signalling. | J Cell Mol Med | 2023 | 36528873 | PubTator, text mining | PubMed |
| Validation and Clinical Application of ONCOaccuPanel for Targeted Next-Generation Sequencing of Solid Tumors. | Cancer Res Treat | 2023 | 36470260 | PubTator, text mining | PubMed |
| Bone morphogenetic protein signaling is a possible therapeutic target in gynecologic cancer. | Cancer Sci | 2023 | 36468782 | PubTator, text mining | PubMed |
| Inclusion body myositis: from genetics to clinical trials. | J Neurol | 2023 | 36399165 | PubTator, text mining | PubMed |
| Core promoter in TNBC is highly mutated with rich ethnic signature. | Brief Funct Genomics | 2023 | 36307127 | PubTator, text mining | PubMed |
| Development of bioinformatics and multi-omics analyses in organoids. | BMB Rep | 2023 | 36284440 | PubTator, text mining | PubMed |
| The astroglial and stem cell functions of adult rat folliculostellate cells. | Glia | 2023 | 36093576 | PubTator, text mining | PubMed |
| Multiomics identifies the link between intratumor steatosis and the exhausted tumor immune microenvironment in hepatocellular carcinoma. | Hepatology | 2023 | 35567547 | PubTator, text mining | PubMed |
| Frequency of microsatellite instability (MSI) in upper tract urothelial carcinoma: comparison of the Bethesda panel and the Idylla MSI assay in a consecutively collected, multi-institutional cohort. | J Clin Pathol | 2023 | 34583948 | PubTator, text mining | PubMed |
| Anti-Obesity Medications and Investigational Agents: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022. | Obes Pillars | 2022 | 37990711 | PubTator, text mining | PubMed |
| Tumorigenesis from non-alcoholic steatohepatitis to hepatocellular carcinoma. | Med Rev (2021) | 2022 | 37724256 | PubTator, text mining | PubMed |
| The comparison of differentially expressed microRNAs in Bag-1 deficient and wild type MCF-7 breast cancer cells by small RNA sequencing. | Turk J Biol | 2022 | 37533517 | PubTator, text mining | PubMed |
| Whole genome sequencing of Malaysian colorectal cancer patients reveals specific druggable somatic mutations. | Front Mol Biosci | 2022 | 36866106 | PubTator, text mining | PubMed |
| Natural history of Echinococcus granulosus microcyst development in long term in vitro culture and molecular and morphological changes induced by insulin and BMP-4. | Front Vet Sci | 2022 | 36699324 | PubTator, text mining | PubMed |
| Epigenetic regulation in premature ovarian failure: A literature review. | Front Physiol | 2022 | 36685174 | PubTator, text mining | PubMed |
| Identification of Circular RNAs of Testis and Caput Epididymis and Prediction of Their Potential Functional Roles in Donkeys. | Genes (Basel) | 2022 | 36672807 | PubTator, text mining | PubMed |
| Activin B and Activin C Have Opposing Effects on Prostate Cancer Progression and Cell Growth. | Cancers (Basel) | 2022 | 36612143 | PubTator, text mining | PubMed |
| Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic Strategies. | Cancers (Basel) | 2022 | 36612019 | PubTator, text mining | PubMed |
| Immune Complex Glomerulonephritis in a Patient with Myelodysplastic Syndrome with Ring Sideroblasts Treated with Luspatercept. | Diagnostics (Basel) | 2022 | 36611303 | PubTator, text mining | PubMed |
| Detection of ROS1 gene fusions using next-generation sequencing for patients with malignancy in China. | Front Cell Dev Biol | 2022 | 36589752 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92/papers?page=13